NCT01392352 2020-02-13HYPAZCambridge University Hospitals NHS Foundation TrustPhase 2 Terminated31 enrolled
NCT00722293 2017-11-13A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid TumorsGlaxoSmithKlinePhase 1 Completed111 enrolled